Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/19600 |
Resumo: | OBJECTIVE: To determine the impact of periodontal treatment on serum levels of prohepcidin (the prohormone of hepcidin) and systemic inflammation markers, as well as correlations among these markers, in patients with chronic periodontitis and chronic kidney disease who were not undergoing dialysis. METHODS: We included 56 chronic periodontitis patients, 36 with chronic kidney disease and 20 without systemic diseases and with normal renal function (control group). Chronic kidney disease was defined as suggested by the clinical practice guidelines in the National Kidney Foundation. Chronic periodontitis was defined through clinical attachment level and by probing pocket depth, according to the American Association of Periodontology. The inflammatory markers ultrasensitive C-reactive protein, interleukin-6, and prohepcidin were evaluated before and 3 months after periodontal treatment. RESULTS: The efficacy of periodontal treatment was confirmed by the improvement in clinical parameters of chronic periodontitis in the control and chronic kidney disease groups. Periodontal treatment resulted in significant reductions in ultrasensitive C-reactive protein, interleukin-6 and serum prohepcidin levels in both groups. Moreover, in multivariate linear regression, the reduction in prohepcidin after periodontal treatment was significantly and independently associated with interleukin-6 levels in the control group. CONCLUSIONS: By inducing a decline in the systemic inflammatory response and a decrease in serum prohepcidin, successful periodontal treatment may represent an important means of ameliorating the inflammatory burden seen in patients with chronic kidney disease. |
id |
USP-19_6bb428447b875cf53c499c642b70e3ff |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/19600 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease Prohepcidinhronic periodontitishronic kidney diseaseinflammatory markersperiodontal treatment OBJECTIVE: To determine the impact of periodontal treatment on serum levels of prohepcidin (the prohormone of hepcidin) and systemic inflammation markers, as well as correlations among these markers, in patients with chronic periodontitis and chronic kidney disease who were not undergoing dialysis. METHODS: We included 56 chronic periodontitis patients, 36 with chronic kidney disease and 20 without systemic diseases and with normal renal function (control group). Chronic kidney disease was defined as suggested by the clinical practice guidelines in the National Kidney Foundation. Chronic periodontitis was defined through clinical attachment level and by probing pocket depth, according to the American Association of Periodontology. The inflammatory markers ultrasensitive C-reactive protein, interleukin-6, and prohepcidin were evaluated before and 3 months after periodontal treatment. RESULTS: The efficacy of periodontal treatment was confirmed by the improvement in clinical parameters of chronic periodontitis in the control and chronic kidney disease groups. Periodontal treatment resulted in significant reductions in ultrasensitive C-reactive protein, interleukin-6 and serum prohepcidin levels in both groups. Moreover, in multivariate linear regression, the reduction in prohepcidin after periodontal treatment was significantly and independently associated with interleukin-6 levels in the control group. CONCLUSIONS: By inducing a decline in the systemic inflammatory response and a decrease in serum prohepcidin, successful periodontal treatment may represent an important means of ameliorating the inflammatory burden seen in patients with chronic kidney disease. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2011-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1960010.1590/S1807-59322011000400022Clinics; Vol. 66 No. 4 (2011); 657-662 Clinics; v. 66 n. 4 (2011); 657-662 Clinics; Vol. 66 Núm. 4 (2011); 657-662 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/19600/21663Vilela, Eduardo MachadoBastos, Jessica AmaralFernandes, NataliaFerreira, Ana PaulaChaoubah, AlfredoBastos, Marcus Gomesinfo:eu-repo/semantics/openAccess2012-05-23T16:50:55Zoai:revistas.usp.br:article/19600Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-23T16:50:55Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease |
title |
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease |
spellingShingle |
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease Vilela, Eduardo Machado Prohepcidin hronic periodontitis hronic kidney disease inflammatory markers periodontal treatment |
title_short |
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease |
title_full |
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease |
title_fullStr |
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease |
title_full_unstemmed |
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease |
title_sort |
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease |
author |
Vilela, Eduardo Machado |
author_facet |
Vilela, Eduardo Machado Bastos, Jessica Amaral Fernandes, Natalia Ferreira, Ana Paula Chaoubah, Alfredo Bastos, Marcus Gomes |
author_role |
author |
author2 |
Bastos, Jessica Amaral Fernandes, Natalia Ferreira, Ana Paula Chaoubah, Alfredo Bastos, Marcus Gomes |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Vilela, Eduardo Machado Bastos, Jessica Amaral Fernandes, Natalia Ferreira, Ana Paula Chaoubah, Alfredo Bastos, Marcus Gomes |
dc.subject.por.fl_str_mv |
Prohepcidin hronic periodontitis hronic kidney disease inflammatory markers periodontal treatment |
topic |
Prohepcidin hronic periodontitis hronic kidney disease inflammatory markers periodontal treatment |
description |
OBJECTIVE: To determine the impact of periodontal treatment on serum levels of prohepcidin (the prohormone of hepcidin) and systemic inflammation markers, as well as correlations among these markers, in patients with chronic periodontitis and chronic kidney disease who were not undergoing dialysis. METHODS: We included 56 chronic periodontitis patients, 36 with chronic kidney disease and 20 without systemic diseases and with normal renal function (control group). Chronic kidney disease was defined as suggested by the clinical practice guidelines in the National Kidney Foundation. Chronic periodontitis was defined through clinical attachment level and by probing pocket depth, according to the American Association of Periodontology. The inflammatory markers ultrasensitive C-reactive protein, interleukin-6, and prohepcidin were evaluated before and 3 months after periodontal treatment. RESULTS: The efficacy of periodontal treatment was confirmed by the improvement in clinical parameters of chronic periodontitis in the control and chronic kidney disease groups. Periodontal treatment resulted in significant reductions in ultrasensitive C-reactive protein, interleukin-6 and serum prohepcidin levels in both groups. Moreover, in multivariate linear regression, the reduction in prohepcidin after periodontal treatment was significantly and independently associated with interleukin-6 levels in the control group. CONCLUSIONS: By inducing a decline in the systemic inflammatory response and a decrease in serum prohepcidin, successful periodontal treatment may represent an important means of ameliorating the inflammatory burden seen in patients with chronic kidney disease. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/19600 10.1590/S1807-59322011000400022 |
url |
https://www.revistas.usp.br/clinics/article/view/19600 |
identifier_str_mv |
10.1590/S1807-59322011000400022 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/19600/21663 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 66 No. 4 (2011); 657-662 Clinics; v. 66 n. 4 (2011); 657-662 Clinics; Vol. 66 Núm. 4 (2011); 657-662 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222757843107840 |